Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

WGS stock hub

GeneDx Holdings Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WGSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

WGS

In the news

Latest news · WGS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E98.4

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-30.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-13.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WGS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001818331
Company name	GeneDx Holdings Corp.
Country	United States
Country code	US
Cusip	81663L200
Employees	1,300
Employees Change	300%
Employees Change Percent	30
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Isin	US81663L2007
Last refreshed	2026-05-10
Market cap	$1.2B
Market cap category	Small-Cap
Price	$40.77
Price currency	USD
Rev Per Employee	340,521.54x
Sector	Healthcare
Sic	8000
Symbol	WGS
Website	https://www.genedx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.43%
EV Sales Forward	2.04x
EV/Sales	2.73x
FCF yield	-2.37%
Forward P/E	98.43x
P/B ratio	4.76x
P/S ratio	2.73x
PS Forward	2.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.52%
EBITDA Margin	-1.77%
Gross margin	69.56%
Gross Profit	$307.9M
Gross Profit Growth	42.9%
Gross Profit Growth Q	16.65%
Gross Profit Growth5 Y	91.82%
Net Income	$-77.8M
Net Income Growth Years	3%
Pretax Margin	-17.5%
Profit Margin	-17.58%
Profit Per Employee	$-59,852
ROA	-4.37
Roa5y	-30.46
ROCE	-7.96
ROE	-30.42
Roe5y	-79.76
ROIC	-13.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-28.91%
Cagr3y	68.3%
Cagr5y	-36.61%
EPS Growth Years	6
Revenue Growth	34.09x
Revenue Growth Q	17.38x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	25.51x
Revenue Growth5 Y	17.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.93
Assets	$506.3M
Cash	$170.7M
Current Assets	$270.6M
Current Liabilities	$87.6M
Debt	$168.2M
Debt EBITDA	$365
Debt Equity	$0.66
Equity	$254.1M
Interest Coverage	-12.73
Liabilities	$252.2M
Long Term Assets	$235.7M
Long Term Liabilities	$164.5M
Net Cash	$2.5M
Net Cash By Market Cap	$0.21
Net Cash Growth	-94.38%
Net Debt Equity	$-0.01
Tangible Book Value	$107.5M
Tangible Book Value Per Share	$3.62
WACC	13.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.09
Inventory Turnover	10.82
Net Working Capital	$17.4M
Quick ratio	2.83
Working Capital	$183M
Working Capital Turnover	$2.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.57%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-28.9%
200-day SMA	108.2
3Y total return	376.84%
50-day SMA	67.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.76%
All Time High	896.9
All Time High Change	-95.45%
All Time High Date	2021-02-12
All Time Low	1.16
All Time Low Change	3,414.66%
All Time Low Date	2023-11-16
ATR	6.18
Beta	2.07
Beta1y	1.78
Beta2y	1.4
Ch YTD	-68.65
High	41.63
High52	170.9
High52 Date	2025-12-02
High52ch	-76.14%
Low	37.57
Low52	32.21
Low52 Date	2026-05-06
Low52ch	26.58%
Ma50ch	-39.69%
Premarket Change Percent	0.67
Premarket Price	$40.77
Premarket Volume	11,280
Price vs 200-day SMA	-62.31%
RSI	31.6
RSI Monthly	41.02
RSI Weekly	28.81
Sharpe ratio	0.04x
Sortino ratio	0.11
Total Return	-5.57%
Tr YTD	-68.65
Tr1m	-39.05%
Tr1w	-37.64%
Tr3m	-51.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$105
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.03
Earnings Revenue Estimate	112,063,552x
Earnings Revenue Estimate Growth	28.64x
Operating Income	$-33.3M
Operating margin	-7.52
Price target	$86.67
Price Target Change	$113
Price Target Change Top	$158

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,215,963%
Float Percent	71.46%
Net Borrowing	21,411,000
Shares Insiders	1.79%
Shares Institutions	89.99%
Shares Out	29,688,027
Shares Qo Q	0.98%
Shares Yo Y	5.57%
Short Float	18.67%
Short Ratio	5.6
Short Shares	13.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-65.8M
Average Volume	1,560,074.2x
Bv Per Share	8.57
CAPEX	$-19.3M
Ch1m	-39.05
Ch1w	-37.64
Ch1y	-28.9
Ch3m	-51.63
Ch3y	376.8
Ch5y	-89.76
Ch6m	-70.82
Change	0.67%
Change From Open	0.12
Close	40.5
Days Gap	0.54
Depreciation Amortization	25,455,000
Dollar Volume	85,859,377.7
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-33.3M
EBITDA	$-7.9M
EPS	$-2.69
F Score	3
FCF	$-28.7M
FCF EV Yield	-2.37x
FCF Per Share	$-0.97
Financing CF	72,897,000
Fiscal Year End	December
Founded	2,017
Goodwill	1,641,000
Income Tax	$334,000
Investing CF	-69,364,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2023-05-04
Last Split Type	Reverse
Last10k Filing Date	2026-02-23
Ma150	105.2
Ma150ch	-61.24%
Ma20	60.55
Ma20ch	-32.66%
Net CF	-5,778,000
Next Earnings Date	2026-07-28
Open	40.72
Optionable	Yes
Position In Range	78.82
Post Close	40.77
Postmarket Change Percent	-0.42
Postmarket Price	$40.6
Ppne	84,778,000
Pre Close	40.5
Price Date	2026-05-08
Ptbv Ratio	11.26
Relative Volume	1.35x
Revenue	442,678,000x
SBC By Revenue	8.4x
Share Based Comp	37,175,000
Tax By Revenue	0.08x
Tr6m	-70.82%
Us State	Connecticut
Volume	2,105,945
Z Score	4.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WGS pay a dividend?

Capital-return profile for this ticker.

Performance

WGS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WGS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Float: +71.5% of shares outstanding

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

WGS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.6

Neutral momentum band

Price vs 200-day MA

-62.3%

50/200-day relationship not available

Beta (5Y)

2.07

More volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WGS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current WGS stock rating?

GeneDx Holdings Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full WGS analysis?

The full report lives at /stocks/WGS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for WGS?

The latest report frames WGS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the WGS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.